ITRM
Iterum Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ITRM Filings
Filing Date
Form Description
Form Type
2025-11-20
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-20 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-14
Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-14 · Earnings Call
Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-14
Form 8-K - Current report
Key Events
2025-11-14 · Key Events
Form 8-K - Current report
2025-10-16
Form 8-K - Current report
Key Events
2025-10-16 · Key Events
Form 8-K - Current report
2025-10-16
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-16 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-09-10
Form 8-K - Current report
Key Events
2025-09-10 · Key Events
Form 8-K - Current report
2025-08-28
Form 8-K - Current report
Key Events
2025-08-28 · Key Events
Form 8-K - Current report
2025-08-20
Form 8-K - Current report
Key Events
2025-08-20 · Key Events
Form 8-K - Current report
2025-08-12
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-08-12 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
